Comparisons of Outcomes of Real-World Patients With Advanced Pancreatic Cancer Treated With FOLFIRINOX Versus Gemcitabine and Nab-Paclitaxel A Population-Based Cohort Study

导出原文传递

翻译打印收藏纠错

作者： Papneja, Neha ^[1] ; Zaidi, Adnan ^[2] ; Chalchal, Haji ^[3] ; Moser, Michael ^[4] ; Tan, Kiat ^[5] ; Olson, Colleen ^[6] ; Haider, Kamal ; Shaw, John ; Ahmed, Shahid

作者单位： McGill Univ, Dept Med, Montreal, PQ, Canada ^[1] Univ Saskatchewan, Dept Surg, Saskatoon, SK, Canada ^[2] Univ Saskatchewan, Allan Blair Canc Ctr, Div Oncol, Regina, SK, Canada ^[3] Saskatchewan Canc Agcy, Dept Pharm, Saskatoon, SK, Canada ^[4] Univ Saskatchewan, Saskatoon Canc Ctr, Div Oncol, Saskatoon, SK, Canada ^[5] Univ Saskatchewan, Dept Radiol, Saskatoon, SK, Canada ^[6]

关键词 metastatic pancreatic cancer FOLFIRINOX gemcitabine nab-paclitaxel advanced pancreatic cancer outcomes real-world patients

发布时间 2019-12-09

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交